Crinetics Pharmaceuticals Announces November 2023
SAN DIEGO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...
Source: globenewswire.com
Page 2 - Chas Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chas Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chas Schultz Today - Breaking & Trending Today
Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Nov. 10, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare...
Source: marketscreener.com
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 10, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare...
Source: marketscreener.com
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
SAN DIEGO, Sept. 20, 2023 -- Crinetics Pharmaceuticals, Inc. today announced that company management will participate in a fireside chat and 1x1 investor meetings at the Cantor Global Healthcare...
Source: marketscreener.com
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Sept. 12, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for...
Source: marketscreener.com